Metformin may affect risk of breast cancer in women with type 2 diabetes

Genetic screening before prescribing could benefit millions
29 January 2021
‘Weak’ and ‘strong’ cells bonding boosts body’s diabetes fight
29 January 2021

Metformin may affect risk of breast cancer in women with type 2 diabetes

A study of 44,541 women has found that there appears to be no association between type 2 diabetes and developing breast cancer overall. This may be because most women in the study with type 2 diabetes were taking metformin, a medication widely used to treat type 2 diabetes, whose actions may help to reduce the risk of developing oestrogen positive (ER-positive) breast cancer.

Comments are closed.